The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes
Open Access
- 1 January 2016
- journal article
- review article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 12 (1), 18-23
- https://doi.org/10.17925/EE.2016.12.01.18
Abstract
Living with type 1 diabetes (T1D) presents many challenges in terms of daily living. Insulin users need to frequently monitor their blood glucose levels and take multiple injections per day and/or multiple boluses through an insulin infusion pump, with the consequences of failing to match the insulin dose to the body's needs resulting in hypoglycaemia and hyperglycaemia. The former can result in seizures, coma and even death; the latter can have both acute and long-term health implications. Many patients with T1D also fail to meet their treatment goals. In order to reduce the burdens of self-administering insulin, and improve efficacy and safety, there is a need to at least partially remove the patient from the loop via a closed-loop 'artificial pancreas’ system. The Hypoglycaemia-Hyperglycaemia Minimizer (HHM) System, comprising a continuous, subcutaneous insulin infusion pump, continuous glucose monitor (CGM) and closed-loop insulin dosing algorithm, is able to predict changes in blood glucose and adjust insulin delivery accordingly to help keep the patient at normal glucose levels. Early clinical data indicate that this system is feasible, effective and safe, and has the potential to dramatically improve the therapeutic outcomes and quality of life for people with T1D.Keywords
This publication has 53 references indexed in Scilit:
- Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness FactorJournal of Diabetes Science and Technology, 2015
- Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing KetosisDiabetes Care, 2015
- A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 DiabetesDiabetes Technology & Therapeutics, 2014
- Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover studyThe Lancet Diabetes & Endocrinology, 2014
- The PILGRIM Study: In Silico Modeling of a Predictive Low Glucose Management System and Feasibility in Youth with Type 1 Diabetes During ExerciseDiabetes Technology & Therapeutics, 2014
- Closed-Loop Control Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System in a Feasibility StudyJournal of Diabetes Science and Technology, 2014
- Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control studyDiabetologia, 2013
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaThe New England Journal of Medicine, 2013
- The Increasing Onset of Type 1 Diabetes in ChildrenThe Journal of Pediatrics, 2012
- Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their durationDiabetologia, 2007